Communications Biology (May 2022)
Targeting aberrant replication and DNA repair events for treating breast cancers
- Subapriya Rajamanickam,
- Jun Hyoung Park,
- Panneerdoss Subbarayalu,
- Santosh Timilsina,
- Kaitlyn Bates,
- Pooja Yadav,
- Saif S. R. Nirzhor,
- Vijay Eedunuri,
- Tabrez A. Mohammad,
- Kwang Hwa Jung,
- Benjamin Onyeagucha,
- Nourhan Abdelfattah,
- Raymond Benevides,
- Grace Lee,
- Yidong Chen,
- Ratna Vadlamudi,
- Andrew Brenner,
- Virginia Kaklamani,
- Ismail Jatoi,
- John Kuhn,
- Robert Hromas,
- Yogesh K. Gupta,
- Benny A. Kaipparettu,
- Jack L. Arbiser,
- Manjeet K. Rao
Affiliations
- Subapriya Rajamanickam
- Greehey Children’s Cancer Research Institute, The University of Texas Health Science Center at San Antonio
- Jun Hyoung Park
- Department of Molecular and Human Genetics, Baylor College of Medicine
- Panneerdoss Subbarayalu
- Greehey Children’s Cancer Research Institute, The University of Texas Health Science Center at San Antonio
- Santosh Timilsina
- Greehey Children’s Cancer Research Institute, The University of Texas Health Science Center at San Antonio
- Kaitlyn Bates
- Greehey Children’s Cancer Research Institute, The University of Texas Health Science Center at San Antonio
- Pooja Yadav
- Greehey Children’s Cancer Research Institute, The University of Texas Health Science Center at San Antonio
- Saif S. R. Nirzhor
- Greehey Children’s Cancer Research Institute, The University of Texas Health Science Center at San Antonio
- Vijay Eedunuri
- Greehey Children’s Cancer Research Institute, The University of Texas Health Science Center at San Antonio
- Tabrez A. Mohammad
- Greehey Children’s Cancer Research Institute, The University of Texas Health Science Center at San Antonio
- Kwang Hwa Jung
- Department of Molecular and Human Genetics, Baylor College of Medicine
- Benjamin Onyeagucha
- Department of Sciences and Mathematics, Mississippi University for Women, Mississippi
- Nourhan Abdelfattah
- Greehey Children’s Cancer Research Institute, The University of Texas Health Science Center at San Antonio
- Raymond Benevides
- Department of Pharmacology, The University of Texas Health Science Center at San Antonio
- Grace Lee
- Department of Pharmacology, The University of Texas Health Science Center at San Antonio
- Yidong Chen
- Greehey Children’s Cancer Research Institute, The University of Texas Health Science Center at San Antonio
- Ratna Vadlamudi
- Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio
- Andrew Brenner
- Department of Medicine and Mays Cancer Center, The University of Texas Health Science Center at San Antonio
- Virginia Kaklamani
- Department of Medicine and Mays Cancer Center, The University of Texas Health Science Center at San Antonio
- Ismail Jatoi
- Department of Surgery, The University of Texas Health Science Center at San Antonio
- John Kuhn
- Department of Sciences and Mathematics, Mississippi University for Women, Mississippi
- Robert Hromas
- Department of Medicine and Mays Cancer Center, The University of Texas Health Science Center at San Antonio
- Yogesh K. Gupta
- Greehey Children’s Cancer Research Institute, The University of Texas Health Science Center at San Antonio
- Benny A. Kaipparettu
- Department of Molecular and Human Genetics, Baylor College of Medicine
- Jack L. Arbiser
- Emory School of Medicine
- Manjeet K. Rao
- Greehey Children’s Cancer Research Institute, The University of Texas Health Science Center at San Antonio
- DOI
- https://doi.org/10.1038/s42003-022-03413-w
- Journal volume & issue
-
Vol. 5,
no. 1
pp. 1 – 17
Abstract
A report of the small molecule Carbazole Blue demonstrates inhibition of breast cancer growth and metastasis without adverse effects on normal tissue.
